Project: Prognostic miRNA-based test for left ventricular remodelling after acute myocardial infarction.

The consortium will develop an innovative diagnostic test to assess the risk of post-acute myocardial infarction (AMI) patients to develop life threatening heart failure (HF). A recently discovered prognostic set of 4 miRNAs will be validated and strengthened for use in a clinical test. Together with clinical information from the patient, the miRNA test will be developed into a new prognostic model for the identification of patients at risk to allow early treatment an monitor treatment response.

Acronym MIPROG (Reference Number: 9686)
Duration 01/11/2015 - 01/11/2018
Project Topic Biological Sciences / Technologies
Network Eurostars 2
Call Eurostars Cut-Off 3

Project partner

Number Name Role Country
21319 Firalis SAS Coordinator France
21320 Lifesequencing S.L. Partner Spain
21321 Luxembourg Institute of Health (LIH) Partner Luxembourg
21322 Medizinische Hochschule Hannover (MHH) Partner Germany